eISSN 2097-6046
ISSN 2096-7446
CN 10-1655/R
Responsible Institution:China Association for Science and Technology
Sponsor:Chinese Nursing Association
Critical Care Research

Nursing care of patients with human parvovirus B19 infection after renal transplantation

  • LIU Hongyan ,
  • AI Ping ,
  • SHEN Qin ,
  • ZHOU Xiaojun ,
  • ZHOU Yefang
Expand

Received date: 2022-04-24

  Online published: 2022-11-11

Abstract

To summarize the nursing experience of human parvovirus B19(HPV-B19) infection after kidney transplantation. Aiming at the problem that patients with HPV-B19 infection after kidney transplantation were prone to rejection,infection and adverse drug reactions during antiviral therapy,the observation of rejection and early symptoms of infection,the guide to take standard immunosuppressive drugs,various measures and health guidance for infection prevention were implemented. Adverse drug reactions were monitored during intravenous immuno-globulin,and a ward HPV-B19 management system was established to prevent the occurrence of complications related to antiviral treatment. Thirty-seven patients with HPV-B19 infection after renal transplantation were dis-charged after comprehensive treatment and nursing. Four patients were hospitalized again because of the recurrence of HPV-B19 infection after discharge,and recovered after hospitalization treatment.

Cite this article

LIU Hongyan , AI Ping , SHEN Qin , ZHOU Xiaojun , ZHOU Yefang . Nursing care of patients with human parvovirus B19 infection after renal transplantation[J]. Chinese Journal of Emergency and Critical Care Nursing, 2022 , 3(6) : 538 -540 . DOI: 10.3761/j.issn.2096-7446.2022.06.012

References

[1] Qiu J,Söderlund-Venermo M,Young NS.Human parvoviruses[J]. Clin Microbiol Rev,2017,30(1):43-113.
[2] Eid AJ,Ardura MI,AST Infectious Diseases Community of Practice. Human parvovirus B19 in solid organ transplantation:guidelines from the American Society of Transplantation Infe-ctious Diseases Community of Practice[J]. Clin Transplant,2019,33(9):e13535.
[3] Nouri M,Kamakifar P,Khodabandehlou N,et al.Association between parvovirus B19 and anemia in HIV-infected patients[J]. Med J Islam Repub Iran,2019,33:137.
[4] 张晓伟. 肾移植术后微小病毒B19感染的临床研究[D]. 上海:中国人民解放军海军军医大学,2020.
Zhang XW.Clinical study of parvovirus B19 infection after renal transplantation[D]. Shanghai:Naval Medical University,2020.
[5] Patil MR,Choudhury AR,Chohwanglim M,et al.Post renal transplant pure red cell aplasia is tacrolimus a culprit?[J]. Clin Kidney J,2016,9(4):603-605.
[6] 李乐之,路潜. 外科护理学[M]. 6版. 北京:人民卫生出版社,2017:192-193.
Li LZ,Lu Q.Surgical nursing[M]. 6th Ed. Beijing:People's Medical Publishing House,2017:192-193.
[7] 李纳,汤姝,朱振峰,等. 肾移植术后应用咪唑立宾和吗替麦考酚酯的有效性和安全性Meta分析[J]. 中国医院药学杂志,2018,38(10):1102-1109.
Li N,Tang S,Zhu ZF,et al.Efficacy and safety of mizoribine and mycophenolate mofetil after renal transplantation:a Meta-analysis[J]. Chin J Hosp Pharm,2018,38(10):1102-1109.
[8] 中华医学会,中华医学会杂志社,中华医学会全科医学分会,等. 痛风及高尿酸血症基层诊疗指南(2019年)[J]. 中华全科医师杂志,2020,19(4):293-303.
Chinese Medical Association,Chinese Medical Association Magazine,General Medicine Branch of Chinese Medical Association,etc. Guidelines for primary diagnosis and treatment of gout and hyperuricemia(2019)[J]. Chin J Gen Pract,2020,19(4):293-303.
[9] Šutová I,Chovancova Z,Litzman J.Adverse effects of immunoglobulin therapy[J]. Vnitr Lek,2019,65(2):131-132.
[10] Rosado-Canto R,Carrillo-Pérez DL,Jiménez JV,et al.Treatment strategies and outcome of parvovirus b19 infection in kidney transplant recipients:a case series and literature review of 128 patients[J]. Rev Invest Clin,2019,71(4):265-274.
Outlines

/